Drug maker Ranbaxy Laboratories is learnt to have partnered another multinational pharmaceuticals company for sourcing active pharmaceutical ingredients, or API, for the generic version of anti-hypertension drug Diovan. Sources said the company had already filed an application with the US regulator, seeking permission for the partnership. A detailed email questionnaire sent to Ranbaxy on Monday did not elicit any response.
Help employers find you! Check out all the jobs and post your resume.
